Pathstone Holdings
TMDX icon

Pathstone Holdings’s Transmedics TMDX Stock Holding History

Pathstone Holdings’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322K Sell
3,238
-3,092
-49% -$403K ﹤0.01% 1944
2025
Q4 		$770K Sell
6,330
-2,340
-27% -$294K ﹤0.01% 1555
2025
Q3 		$973K Buy
8,670
+17
+0.2% +$1.99K ﹤0.01% 1443
2025
Q2 		$1.16M Sell
8,653
-1,619
-16% -$178K ﹤0.01% 1313
2025
Q1 		$691K Sell
10,272
-6,399
-38% -$440K ﹤0.01% 1556
2024
Q4 		$1.04M Sell
16,671
-9,710
-37% -$904K ﹤0.01% 1353
2024
Q3 		$4.14M Buy
26,381
+1,231
+5% +$190K 0.02% 621
2024
Q2 		$3.79M Buy
25,150
+8,741
+53% +$1.05M 0.02% 632
2024
Q1 		$1.21M Buy
16,409
+12,522
+322% +$1.03M 0.01% 1167
2023
Q4 		$307K Buy
+3,887
New +$234K ﹤0.01% 1808

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathstone Holdings's TMDX Position: Q1 2026 in Review

Pathstone Holdings reduced its Transmedics (TMDX) stake by 49% in Q1 2026, selling an estimated $403K and leaving 3,238 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

Pathstone Holdings first reported a position in TMDX in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.14M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Pathstone Holdings held 3,238 shares of Transmedics worth $322K as of Q1 2026.
  • Pathstone Holdings sold 3,092 Transmedics shares in Q1 2026, an estimated $403K.
  • Transmedics made up ﹤0.01% of Pathstone Holdings's portfolio in Q1 2026, its #1944 holding.
  • Pathstone Holdings first reported a position in Transmedics in Q4 2023 and has held it in 10 quarters since.
  • Pathstone Holdings's Transmedics position peaked at $4.14M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.